Experimental Drug Slows Decline In Alzheimer's Patients
One year ago - By Active Beat
Combined results from two studies show that Solanezumab, an Alzheimer's drug being developed by Eli Lilly & Co., might slow mental decline, particularly in milder Alzheimer's cases. The results were announced on Monday by researchers at a conference of the American Neurological Association in Boston.
While the separate studies showed that the drug did not achieve the main goal of slowing the progress of Alzheimer's significantly, pooled results found that mild Alzheimer's patients administered with Solanezumab showed a 34 percent smaller decline compared to those given a placebo for 18...
Read more ...Innovative Treatment Could Slow Down Alzheimer's Disease
One year ago - By Active Beat
Solanezumab, a new drug created by Eli Lilly has shown promising results in two trails to clear plaques that are believed to be the cause of Alzheimer's. This is a major achievement for Eli Lilly as there only a few drugs that have been shown to make a difference in delaying this degenerative disease. The drugs currently approved for Alzheimer's treatments only help by eliminating symptoms not by treating the disease.
In the two trials conducted solanezumab was effective in reducing the cognitive decline experienced by patients by 34%. The drug appears to work best on patients who at the...
Read more ...
The headlines of Master Doctor
With Input from MHAC, ‘Connecting Communities through Digital Equity' Report...
The Massachusetts Healthy Aging Collaborative is grateful to have participated in a working group led by MassINC and the Massachusetts Competitive Partnership that informed a...
VIDEO: Lundberg speaks on ischemia in women, CV effects of menopause hormone...
PHILADELPHIA - In this Healio video exclusive, Gina Lundberg, MD, FACC, provides an overview of the Heart in Diabetes CME conference presentation, titled “CVD in Women...
Key protein α-synuclein linked to inflammation and Parkinson's disease
Currently, there are no disease modifying therapies for Parkinson's disease that can change the progression of the disease. An international team of scientists led by faculty...
Blueberries - The Super Food to Eat Now
Healthy Aging Magazine excerpt
Happy Easter - Easy Decorating Idea
Easy, fun idea for Easter centerpiece
Family doctors 'don't know enough' about menopause so women are turning to...
'Distressed' women are turning to friends and the internet for menopause advice because their GPs do not know enough about the subject, a study by think-tank the Health...
Age-Friendly Job Alerts: Age/Dementia Friendly Franklin County-North...
Check out the following job opportunities that advance inclusive age- and dementia friendly communities: Age-Friendly Program Coordinator - LifePath The Age-Friendly Program...
Mark Butler to order snap vaccine inquiry into COVID-19 purchasing
Health Minister Mark Butler will have a senior former public servant run a snap inquiry into Australia's COVID-19 vaccine purchasing plans.
Study finds more of white matter hyperintensities in postmenopausal women
Women who have gone through menopause may have more of a brain biomarker called white matter hyperintensities than premenopausal women or men of the same age, according to a...
Brain MRIs and genetics may be used to predict the chances of developing...
Simon Fraser University researchers are studying how a combination of genetics and brain MRIs may be used to predict the chances of developing Alzheimer's disease in the future.